114 related articles for article (PubMed ID: 26091511)
21. Oral Kaposi's sarcoma in Tanzania: presentation, immunopathology and human herpesvirus-8 association.
Mwakigonja AR; Pak F; Pyakurel P; Mosha IJ; Urassa WK; Kaaya EE; Biberfeld P
Oncol Rep; 2007 Jun; 17(6):1291-9. PubMed ID: 17487381
[TBL] [Abstract][Full Text] [Related]
22. mTOR, VEGF, PDGFR, and c-kit signaling pathway activation in Kaposi sarcoma.
Kerr DA; Busarla SVP; Gimbel DC; Sohani AR; Nazarian RM
Hum Pathol; 2017 Jul; 65():157-165. PubMed ID: 28506734
[TBL] [Abstract][Full Text] [Related]
23. Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma.
Dupuy S; Lambert M; Zucman D; Choukem SP; Tognarelli S; Pages C; Lebbé C; Caillat-Zucman S
PLoS Pathog; 2012 Jan; 8(1):e1002486. PubMed ID: 22253598
[TBL] [Abstract][Full Text] [Related]
24. Utility of immunohistochemical staining with FLI1, D2-40, CD31, and CD34 in the diagnosis of acquired immunodeficiency syndrome-related and non-acquired immunodeficiency syndrome-related Kaposi sarcoma.
Rosado FG; Itani DM; Coffin CM; Cates JM
Arch Pathol Lab Med; 2012 Mar; 136(3):301-4. PubMed ID: 22372906
[TBL] [Abstract][Full Text] [Related]
25. Detection of HHV-8 in pyogenic granuloma-like Kaposi sarcoma.
Urquhart JL; Uzieblo A; Kohler S
Am J Dermatopathol; 2006 Aug; 28(4):317-21. PubMed ID: 16871034
[TBL] [Abstract][Full Text] [Related]
26. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
[TBL] [Abstract][Full Text] [Related]
27. Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease.
Amin HM; Medeiros LJ; Manning JT; Jones D
Am J Surg Pathol; 2003 Jan; 27(1):91-100. PubMed ID: 12502931
[TBL] [Abstract][Full Text] [Related]
28. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.
Guihot A; Dupin N; Marcelin AG; Gorin I; Bedin AS; Bossi P; Galicier L; Oksenhendler E; Autran B; Carcelain G
J Infect Dis; 2006 Oct; 194(8):1078-88. PubMed ID: 16991082
[TBL] [Abstract][Full Text] [Related]
29. Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease.
Brousset P; Cesarman E; Meggetto F; Lamant L; Delsol G
Hum Pathol; 2001 Jan; 32(1):95-100. PubMed ID: 11172301
[TBL] [Abstract][Full Text] [Related]
30. Unique histologic variants of cutaneous Kaposi sarcoma.
OʼDonnell PJ; Pantanowitz L; Grayson W
Am J Dermatopathol; 2010 May; 32(3):244-250. PubMed ID: 20075709
[TBL] [Abstract][Full Text] [Related]
31. Human herpesvirus-8 latent nuclear antigen-1 expression in endemic Kaposi sarcoma: an immunohistochemical study of 16 cases.
Schwartz EJ; Dorfman RF; Kohler S
Am J Surg Pathol; 2003 Dec; 27(12):1546-50. PubMed ID: 14657714
[TBL] [Abstract][Full Text] [Related]
32. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma.
Liu W; Lacouture ME; Jiang J; Kraus M; Dickstein J; Soltani K; Shea CR
J Cutan Pathol; 2006 Sep; 33 Suppl 2():46-51. PubMed ID: 16972955
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma, a South African perspective: Demographic and pathological features.
Mohanlal RD; Pather S
S Afr Med J; 2015 Apr; 105(5):375-8. PubMed ID: 26242669
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of HHV8 in a cohort of HIV-negative and HIV-positive patients in Mozambique.
Ceffa S; Buonomo E; Altan AM; Erba F; Germano P; Guidotti G; Liotta G; Magnano San Lio M; Scarcella P; Palombi L; Marazzi MC
Ann Ig; 2007; 19(6):519-23. PubMed ID: 18376572
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of c-kit expression in classic Kaposi's sarcoma in a cohort of Egyptian patients.
Hussein TM; El-Sabaa BM; Hanafy NF
J Egypt Natl Canc Inst; 2012 Mar; 24(1):1-6. PubMed ID: 23587226
[TBL] [Abstract][Full Text] [Related]
36. Stage-related PD-L1 expression in Kaposi sarcoma tumor microenvironment.
Joest B; Kempf W; Berisha A; Peyk P; Tronnier M; Mitteldorf C
J Cutan Pathol; 2020 Oct; 47(10):888-895. PubMed ID: 32310306
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic Kaposi's Sarcoma of the Adrenal in an HIV-negative Patient With Literature Review.
Bisceglia M; Minenna E; Altobella A; Sanguedolce F; Panniello G; Bisceglia S; Ben-Dor DJ
Adv Anat Pathol; 2019 Mar; 26(2):133-149. PubMed ID: 30212382
[TBL] [Abstract][Full Text] [Related]
38. Human bcl-2 expression, cleaved caspase-3, and KSHV LANA-1 in Kaposi sarcoma lesions.
Ramos da Silva S; Bacchi MM; Bacchi CE; Elgui de Oliveira D
Am J Clin Pathol; 2007 Nov; 128(5):794-802. PubMed ID: 17951202
[TBL] [Abstract][Full Text] [Related]
39. Disseminated Kaposi sarcoma in a HIV negative patient.
Lin G; Wang H; Fan X; Li H; Wang Z; Lin D; Yang S; Zhang X
Int J Clin Exp Pathol; 2015; 8(3):3378-80. PubMed ID: 26045873
[TBL] [Abstract][Full Text] [Related]
40. LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.
Long E; Ilie M; Hofman V; Havet K; Selva E; Butori C; Lacour JP; Nelson AM; Cathomas G; Hofman P
Virchows Arch; 2009 Aug; 455(2):159-70. PubMed ID: 19484260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
